Carotenoid oxidative degradation products inhibit Na⁺-K⁺-ATPase

References

• Krinsky N.I. Carotenoid protection against oxidation. Pure and Applied Chemistry 1979; 51: 649–660
   Web of Science ®Google Scholar
• Burton G.W., Ingold K.U. β-Carotene: An unusual type of lipid antioxidant. Science 1984; 224: 569–573
   PubMed Web of Science ®Google Scholar
• Sies H., Stahl W., Sundquist A.R. Antioxidant functions of vitamins. Vitamins E and C, b-carotene, and other carotenoids. Annals of the New York Academy of Sciences 1992; 669: 7–20
   PubMed Web of Science ®Google Scholar
• Liebler D.C. Antioxidant reactions of carotenoids. Annals of the New York Academy of Sciences 1993; 691: 20–31
   PubMed Web of Science ®Google Scholar
• Seddon J.M., Ajani U.A., Sperduto R.D., Hiller R., Blair N., Burton T.C., Farber M.D., Gragoudas E.S., Haller J., Miller D.T., Yannuzzi L.A., Willett W. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Journa of the American Medical Association 1994; 272: 1413–1420
   PubMed Web of Science ®Google Scholar
• α-Tocopherol, β-Carotene and Cancer Prevention Study Group (ATBC). The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine 1994; 330: 1029–1035
   Google Scholar
• Mayne S.T. Beta-carotene, carotenoids, and disease prevention in humans. FASEB Journal 1996; 10: 690–701
   PubMed Web of Science ®Google Scholar
• Omaye S.T., Krinsky N.I., Kagan V.E., Mayne S.T., Liebler D.C., Bidlack W.R. β-Carotene: friend or foe?. Fundamental and Applied Toxicology 1997; 40: 163–174
   PubMedGoogle Scholar
• Paolini M., Cantelli-Forti G., Perocco P., Pedulli G.F., Abdel-Rahman S.Z., Legator M.S. Co-carcinogenic effect of β-carotene. Nature 1999; 398: 760–761
   PubMed Web of Science ®Google Scholar
• Gradelet S., Leclerc J., Siess M.H., Astorg P.O. β-Apo-8′-carotenal, but not β-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 1996; 26: 909–919
   PubMed Web of Science ®Google Scholar
• Krinsky N.I. Carotenoid metabolites as cell signaling modulators. Oxidants and Antioxidants in Biology, L. Packer, K.J.A. Davies, E. Cadenas. Oxygen Club, Santa Barbara 1999; 6–6, In abstract book
   Google Scholar
• Handelman G.J., van Kuijk F.J.G.M., Chatterjee A., Krinsky N.I. Characterization of products formed during the autoxidation of β-carotene. Free Radical Biology and Medicine 1991; 10: 427–437
   PubMed Web of Science ®Google Scholar
• Siems W.G., Hapner S.J., van Kuijk F.J.G.M. 4-Hydroxynonenal inhibits Na+-K+-ATPase. Free Radical Biology and Medicine 1996; 20: 215–223
   PubMed Web of Science ®Google Scholar
• Siems W.G., Capuozzo E., Verginelli D., Salerno C., Crifo C., Grune T. Inhibition of NADPH oxidase-mediated superoxide radical formation in PMA-stimulated human neutrophils by 4-hydroxynonenal binding to -SH and -NH2 groups. Free Radical Research 1997; 27: 353–358
   PubMed Web of Science ®Google Scholar
• Uchida K., Stadtman E.R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 4544–4548
   PubMed Web of Science ®Google Scholar
• Uchida K., Stadtman E.R. Selective cleavage of thioether linkage in proteins modified with 4-hydroxynonenal. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 5611–5615
   PubMed Web of Science ®Google Scholar
• Szweda L.I., Uchida K., Tsai L., Stadtman E.R. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxynonenal: Selective modification of an active-site lysine. Journal of Biological Chemistry 1993; 268: 3342–3347
   PubMed Web of Science ®Google Scholar
• Uchida K., Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase: A possible involvement of intra- and intermolecular cross-linking reaction. Journal of Biological Chemistry 1993; 268: 6388–6393
   PubMed Web of Science ®Google Scholar
• Sommerburg O., Ullrich O., Sitte N., von Zglinicki D., Siems W., Grune T. Dose- and wavelength-dependent oxidation of crystallins by UV light-selective recognition and degradation by the 20S proteasome. Free Radical Biology and Medicine 1999; 24: 1369–1374
   Google Scholar
• Rees M.S., van Kuijk F.J.G.M., Stephens R.J., Mundy B.P. Synthesis of deuterated 4-hydroxyalkenals. Synthetic Communications 1993; 23: 757–763
   Web of Science ®Google Scholar
• Craft N.E., Soares J.H. Relative solubility, stability, and absorptivity of lutein and β-carotene in organic solvents. Agricultural and Food Chemistry 1992; 40: 431–434
   Web of Science ®Google Scholar
• Sommerburg O., Zang L.Y., van Kuijk F.J.G.M. Simultaneous detection of carotenoids and vitamin E in human plasma. Journal of Chromatography B 1997; 695: 201–207
   PubMedGoogle Scholar
• van Kuijk F.J.G.M., Handelman G.J., Dratz E.A. Rapid analysis of the major classes of retinoid by step gradient reversed-phase high performance liquid chromatography using retinal (O-ethyl) oxime derivatives. Journal of Chromatography 1985; 348: 241–251
   PubMedGoogle Scholar
• Schoot B.M., de Pont J.J.H.H.M., Bonting S.L. Studies on (Na+ + K+)-activated ATPase, XLII: Evidence for two classes of essential sulhydryl groups. Biochimica Biophysica Acta 1978; 522: 602–613
   PubMedGoogle Scholar
• Feschenko M.S., Wetzel R.K., Sweadner K.J. Phosphorylation of Na,K-ATPase by protein kinases. Sites, susceptibility, and consequences. Annals of the New York Academy of Sciences 1997; 834: 479–488
   PubMedGoogle Scholar
• Feschenko M.S., Sweadner K.J. Phosphorylation of Na,K-ATPase by protein kinase C at Ser18 occurs in intact cells but does not result in direct inhibition of ATP hydrolysis. Journal of Biological Chemistry 1997; 272: 17726–17733
   PubMed Web of Science ®Google Scholar
• Bertorello A.M., Aperia A., Walaas S.I., Nairn A.C., Greengard P. Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 11359–11362
   PubMed Web of Science ®Google Scholar
• Daly S.E., Lane L.K., Blostein R. Cytoplasmic regions of the alpha subunit of the sodium pump involved in modulating the Na,K-ATPase reaction. Annals of the New York Academy of Sciences 1997; 834: 489–497
   PubMedGoogle Scholar
• Colonna T., Kostich M., Hamrick M., Hwang B., Rawn J.D., Fambrough D.M. Subunit interactions in the sodium pump. Annals of the New York Academy of Sciences 1997; 834: 498–513
   PubMedGoogle Scholar
• Zollner H. Handbook of Enzyme Inhibitors, Part A. VCH Verlagsgesellschaft mbh, Weinheim, Basel, New York 1993; 340–344, In
   Google Scholar
• Goto A., Yamada K., Yagi N., Yoshioka M., Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacological Reviews 1992; 44: 377–399
   PubMed Web of Science ®Google Scholar
• Balzan S., Montali U., Ghione S. Evidence of an endogenous ouabain-like immunoreactive compound with digitalis-like properties in the human. Annals of the New York Academy of Sciences 1997; 834: 626–630
   PubMedGoogle Scholar
• Ludens J.H., Clark M.A., DuCharme D.W., Harris D.W., Lutzke B.S., Mandel F., Mathews W.R., Sutter D.M., Hamlyn J.M. Purification of an endogenous digitalis-like factor from human plasma for structural analysis. Hypertension 1991; 17: 923–929
   PubMed Web of Science ®Google Scholar
• Hamlyn J.M., Manunta P. Ouabain, digitalis-like factors and hypertension. Journal of Hypertension 1992; 10: S99–S111
   Web of Science ®Google Scholar
• Zhao N., Lo L.C., Berova N., Nakanishi K., Tymiak A.A., Ludens J.H., Haupert G.T., Jr. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: Nanogram scale CD structural analysis. Biochemistry 1995; 34: 9893–9896
   PubMed Web of Science ®Google Scholar
• Lichtstein D., Gati I., Samuelov S., Berson D., Rozenman Y., Landau L., Deutsch J. Identification of digitalis-like compounds in human cataractous lenses. European Journal of Biochemistry 1993; 216: 261–268
   PubMedGoogle Scholar
• Sakakibara M., Uchida A.O. Syntheses of (14 beta,15 beta,16 beta,17 alpha)- and (14beta, 15 alpha,16 alpha,17 alpha)-1,3,5(10)-estratriene-2,3,14,15,16,17-hexaols, possible candidates for the Inagami-Tamura endogenous digitalis-like factor, and their activity. Bioscience Biotechnology and Biochemistry 1996; 60: 405–410
   PubMed Web of Science ®Google Scholar
• Rodriguez de Lores Arnaiz G., Mistorigo de Pacheco M. Regulation of (Na+,K+)adenosinetriphosphatase of nerve ending membranes: Action of norepinephrine and a soluble factor. Neurochemical Research 1978; 3: 733–744
   PubMedGoogle Scholar
• Rodriguez de Lores Arnaiz G., Reines A., Herbin T., Pena C. Kinetics of Na+-K+-ATPase inhibition by brain endobains. Annals of the New York Academy of Sciences 1997; 834: 642–645
   PubMedGoogle Scholar
• Rodriguez de Lores Arnaiz G., Pena C. Characterization of synaptosomal membrane Na+-K+-ATPase inhibitors. Neurochemistry International 1995; 27: 319–327
   PubMedGoogle Scholar
• Skou J.C., Hilberg C. The effect of sulfhydrylblocking reagents and of urea on the (Na++K+)-activated enzyme system. Biochimica Biophysica Acta 1965; 110: 359–369
   PubMedGoogle Scholar
• Xu K. Any of several lysines can react with 5′-isothiocyanatofluorescein to inactivate sodium and potassium ion activated adenosinetriphosphatase. Biochemistry 1989; 28: 5764–5772
   PubMedGoogle Scholar
• Winslow J.W. The reaction of sulfhydryl groups of sodium and potassium ion-activated adenosine triphosphatase with N-ethylmaleimide. Journal of Biological Chemistry 1981; 256: 9522–9531
   PubMedGoogle Scholar
• Schoot B.M., Schoots A.F.M., de Pont J.J.H.H.M., SchuurmansStekhoven F.M.A.H., Bonting S.L. Studies on (Na+ + K+) activated ATPase, XLI: Effects of N-ethylmaleimide on overall and partial reactions. Biochimica Biophysica Acta 1977; 483: 181–192
   PubMedGoogle Scholar
• Tobin T., Akera T. Showdomycin, A nucleotidesite directed inhibitor of (Na++K+)-ATPase. Biochimica Biophysica Acta 1975; 389: 126–136
   PubMedGoogle Scholar
• Askari A., Huang W., Henderson G.R. Na,K,-ATPase: Functional and structural modifications induced by mercurials. Na,K-ATPase: Structure and kinetics, J.C. Skou, J.G. Nørby. Academic Press, New York 1979; 205–215, In
   Google Scholar
• Kim M., Akera T. O2 free radicals cause of ischemia-reperfusion injury to cardiac Na+K+-ATPase. American Journal of Physiology 1987; 252: H252–H257
   PubMed Web of Science ®Google Scholar
• Kurella E., Kukley M., Tyulina O., Dobrota D., Matejovicova M., Mezesova V., Boldyrev A. Kinetic parameters of Na/K-ATPase modified by free radicals in vitro and in vivo. Annals of the New York Academy of Sciences 1997; 834: 661–665
   PubMed Web of Science ®Google Scholar
• Mintorovitch J., Yang G.Y., Shimizu H., Kucharczyk J., Chan P.H., Weinstein P.R. Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: Comparison of signal intensity with changes in brain water and Na+,K(+)-ATPase activity. Journal of Cerebral Blood Flow and Metabolism 1994; 14: 332–336
   PubMedGoogle Scholar
• Boldyrev A.A., Bulygina E.R. Na/K-ATPase and oxidative stress. Annals of the New York Academy of Sciences 1997; 834: 666–668
   PubMedGoogle Scholar
• Huang W.H., Wang Y.H., Askari A. Na-K-ATPase: Inactivation and degradation induced by oxygen radicals. International Journal of Biochemistry 1992; 24: 621–626
   PubMedGoogle Scholar
• Xu K.Y., Zweier J.L., Becker L.C. Oxygen-free radicals directly attack the ATP binding site of the cardiac Na+,K(+)-ATPase. Annals of the New York Academy of Sciences 1997; 834: 680–683
   PubMedGoogle Scholar
• van Kuijk F.J.G.M. 4-Hydroxynonenal interaction with rhodopsin. Biochemical and Biophysical Research Communications 1997; 230: 275–279
   PubMedGoogle Scholar
• Siems W.G., Zollner H., Grune T., Esterbauer H. Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. Journal of LIpid Research 1997; 38: 612–622
   PubMed Web of Science ®Google Scholar
• Siems W.G., Pimenov A.M., Esterbauer H., Grune T. Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in thymocytes as an effective secondary antioxidative defense mechanism. Journal of Biochemistry 1998; 123: 534–539
   PubMedGoogle Scholar
• Grune T., Siems W.G., Zollner H., Esterbauer H. Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages. Cancer Research 1994; 54: 5231–5235
   PubMed Web of Science ®Google Scholar
• Olson J.A. The conversion of carotene to vitamin A (Thomas Moore, 1930). Journal of Nutrition 1997; 127: 1036S–1038S
   Google Scholar
• Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation: 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. Journal of Biological Chemistry 1999; 274: 2234–2242
   PubMed Web of Science ®Google Scholar